Recruitment of approximately 35 of the world’s foremost researchers in critical health care disciplines,
including oncology and neurosurgery.
Recruitment of more than 250 clinical faculty at Robert Wood Johnson Medical School and Rutgers New Jersey
Medical School.
Major investment in the Rutgers Cancer Institute of New Jersey, including a joint project to build a $750
million cancer pavilion in New Brunswick.
Establishment of a $10 million fund to retain its top medical students and hire them within the shared
health system.
Development of a state-of-the-art clinical trial infrastructure, which supported COVID-19 vaccine trials
by pharmaceutical companies
Johnson & Johnson and Moderna, among other critical pandemic
studies.